Skip to Main Content

Paper Details

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer.
Elife
296
2014
cancer, cancers, human, mitochondria, mitochondrial DNA, mitochondrial heavy strand, mtDNA, mtDNA sequence, nuclear cancer genomes, nuclear genomes, replicative, tumor, tumors
Author NameAffiliation
Ludmil B AlexandrovWellcome Trust Sanger Institute
Ludmil B AlexandrovWellcome Trust Sanger Institute
Moritz GerstungWellcome Trust Sanger Institute
Inigo MartincorenaWellcome Trust Sanger Institute
Serena Nik-ZainalWellcome Trust Sanger Institute
Manasa RamakrishnaWellcome Trust Sanger Institute
Gunes GundemWellcome Trust Sanger Institute
Patrick S TarpeyWellcome Trust Sanger Institute
Charlie E MassieWellcome Trust Sanger Institute
Adam ButlerWellcome Trust Sanger Institute
Jon TeagueWellcome Trust Sanger Institute
Adel K El-NaggarMD Anderson Cancer Center
Adel K El-NaggarMD Anderson Cancer Center
Vincent Peter CollinsCambridge University Hospitals NHS Foundation Trust
David Neil HayesUniversity of North Carolina
David Neil HayesUniversity of North Carolina
David MalkinHospital for Sick Children, University of Toronto
David MalkinHospital for Sick Children, University of Toronto
Christopher S FosterDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool
Anne Y WarrenCambridge University Hospitals NHS Foundation Trust
Hayley C WhitakerCancer Research UK Cambridge Institute, University of Cambridge
Daniel S BrewerInstitute of Cancer Research
Rosalind A EelesInstitute of Cancer Research
Colin S CooperInstitute of Cancer Research
David E NealCancer Research UK Cambridge Institute, University of Cambridge
Tapio VisakorpiInstitute of Biosciences and Medical Technology - BioMediTech and Fimlab Laboratories, University of Tampere and Tampere University Hospital
William B IsaacsJohns Hopkins University
George Steven BovaInstitute of Biosciences and Medical Technology - BioMediTech and Fimlab Laboratories, University of Tampere and Tampere University Hospital
Adrienne M FlanaganRoyal National Orthopaedic Hospital
Adrienne M FlanaganRoyal National Orthopaedic Hospital
Phillip A FutrealWellcome Trust Sanger Institute
Andy G LynchCancer Research UK Cambridge Institute, University of Cambridge
Patrick F ChinneryInstitute of Genetic Medicine, Newcastle University
Ultan McDermottWellcome Trust Sanger Institute
Michael R StrattonWellcome Trust Sanger Institute
Peter J CampbellWellcome Trust Sanger Institute
  • 1 - 36

Datasets

Release 1.2